Avaxia Biologics Receives $1,005,777 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0af77390-cd12-4df3-b374-64aac005114b
Date
7/21/2015
Company Name
Avaxia Biologics
Mailing Address
128 Spring Street Lexington, MA 02421 USA
Company Description
Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract.
Website
http://www.avaxiabiologics.com
Transaction Type
Debt
Transaction Amount
$1,005,777
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed